Calbindin 2 as a Novel Biomarker and Therapeutic Target for Abdominal Aortic Aneurysm: Integrative Analysis of Human Proteomes and Genetics

Background Abdominal aortic aneurysm (AAA) is a clinical life‐threatening issue. No pharmacological treatments are currently approved for the prevention and treatment of AAA. Therefore, identifying novel biomarkers and therapeutic targets is crucial for improving AAA management and outcomes. Methods...

Cijeli opis

Bibliografski detalji

Glavni autori:	Yulin Bao, Jiayi Chen, Xudong Han, Ye He, Tongtong Yang, Xinying Shi, Jiawen Chen, Lingfeng Gu, Sibo Wang, Liping Xie, Hao Wang, Liansheng Wang
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2025-05-01
Serija:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Teme:	abdominal aortic aneurysm calbindin 2 Mendelian randomization plasma protein proteogenomic
Online pristup:	https://www.ahajournals.org/doi/10.1161/JAHA.124.039195
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!